Transcription mediated by hypoxia inducible factor (HIF-1) contributes to tumor angiogenesis and metastasis but is also involved in the activation of cell-death pathways and normal physiological processes. Given the complexity of HIF-1 signaling it could be advantageous to target a subset of HIF-1 effectors rather than the entire pathway. We compared the genome-wide effects of three molecules that each interfere with the HIF-1-DNA interaction: a polyamide targeted to the hypoxia response element (HRE), siRNA targeted to HIF-1α, and echinomycin, a DNA binding natural product with a similar but less specific sequence preference to the polyamide. The polyamide affects a subset of hypoxia-induced genes that are consistent with the binding site preferences of the polyamide. For comparison, siRNA targeted to HIF-1α and echinomycin each affect the expression of nearly every gene induced by hypoxia. Remarkably, the total number of genes affected by either polyamide or HIF-1α siRNA over a range of thresholds is comparable. The data show how polyamides can be used to affect a subset of a pathway regulated by a transcription factor. In addition, this study offers a unique comparison of three complementary approaches toward exogenous control of endogenous gene expression.
Introduction
Exogenous chemical and biological methods to control directly the expression of selected endogenous genes could have broad implications for human medicine. Toward this goal, a number of technological approaches are currently being investigated.
Polydactyl zinc finger proteins are a programmable class of DNA binding proteins capable of sequence-specific binding (1, 2) . These designed proteins have been used to inhibit expression of target genes (3) , and conjugates of zinc finger proteins and transcriptional activator domains have been used to activate the expression of target genes (4) . The RNA-interference pathway can be used to regulate gene expression at the post-transcriptional level (5) . siRNA and shRNA molecules enlist cellular machinery to degrade selected mRNA targets (6, 7) . RNAi technology has been highly effective in achieving potent and specific knock-down of target mRNAs and is now widely used to probe functions of target genes (8) . However, bioavailability and delivery of zinc finger proteins and siRNA, or vectors that code for them, to targets in humans could be an obstacle to their therapeutic application and continues to receive considerable attention (8) . Cell-permeable small molecules that modulate protein-protein or protein-DNA interactions offer another approach to the control of endogenous gene regulation.
Screening small molecule and natural product libraries for a desired effect can identify candidate molecules that have a high likelihood of possessing drug-like bioavailability.
Drawbacks include the need to screen anew for each target protein-protein or protein-DNA interaction. Polyamides containing N-methylimidazole (Im) and N-methylpyrrole (Py) are a class of programmable DNA-binding small molecules that have been used to disrupt protein-DNA interactions in a sequence specific manner in cell culture (9) .
Controlling the transcriptional activity of the hypoxia inducible factor (HIF-1), a heterodimer of HIF-1α and HIF-1β (ARNT), is a goal with clinical relevance (10) (11) (12) (13) .
HIF-1 is the principal mediator of the adaptive cellular response to hypoxia (14) . Under normoxic conditions, the α subunit of HIF-1 is specifically hydroxylated by an irondependent proline hydroxylase, ubiquitinated by the von Hippel-Lindau (VHL) tumor suppressor protein-ubiquitin ligase protein complex, and degraded by the proteosome (15) . Iron chelators, such as deferoxamine (DFO), can be used to mimic hypoxia in cell culture (15) . Through interaction with co-activators p300/CBP, HIF-1 directly activates the expression of at least 100 genes that are involved with cellular and tissue adaptation to hypoxia (12) . This set includes pro-angiogenic factors such as vascular endothelial growth factor (VEGF), glycolytic enzymes, extra-cellular matrix remodeling enzymes, and genes involved in both pro-survival and death pathways (10) . HIF-1 activation by the hypoxic microenvironment of solid tumors, or additionally by deactivating mutations in VHL, contributes to an aggressive phenotype of increased cell proliferation, invasion, metastasis, and drug resistance (10) . Given the complexity of HIF-1 signaling in cellular survival and death pathways, and its critical role in physiological processes in normal tissues, it could be advantageous to target a subset of HIF-1 effectors rather than the entire pathway (12) .
In important proof of principle experiments, introduction of siRNA against HIF-2α to VHL -/-renal carcinoma cells was sufficient to abrogate tumor formation by these cells in mice (16) . Screening for small molecules capable of disrupting the HIF-1-p300
interaction identified chetomin, a natural product that binds p300 that was shown to inhibit expression of HIF-1 regulated genes and exhibit anti-tumor activity in a mouse model (17) . In an effort to inhibit directly the HIF-1 binding to DNA, a hairpin polyamide was designed to bind the sequence 5'-ATACGT-3' found in the HRE of VEGF. This polyamide bound its target site and prevented HIF-1-DNA binding in a sequence specific manner, and inhibited hypoxia-induced expression of VEGF and several other HIF-1 regulated genes in cultured cells without the use of transfection agents (18, 19) . Melillo and colleagues screened a library of small molecules for inhibition of HIF-1 mediated transcription in a cell-based assay and identified the natural product echinomycin, a DNA-binding bisintercalator (20) . Echinomycin binds the four base pair sequence 5'-NCGN-3' found in the consensus HRE 5'-NACGTG-3' and inhibited expression of VEGF in cultured cells (21) .
To Remarkably, the total number of genes affected by either polyamide 1 or HIF-1α siRNA over a range of thresholds is comparable. We show that HIF-1 occupancy at the HREs of two genes affected by polyamide 1 is reduced in the presence of the polyamide, while HIF-1 occupancy at the HREs of two unaffected genes is unchanged. We also show that a polyamide that binds a site immediately 5' to the HRE of the VEGF promoter inhibits induced expression of VEGF but not of FLT1, a HIF-1 target gene lacking this flanking site. 
Results

Binding of Polyamide 1, 2 and Echinomycin at the VEGF and FLT1 HREs
Polyamide sequence specificity is programmed by side-by- echinomycin, it may be surprising that 1 μM of polyamide 1 is necessary to inhibit VEGF and FLT1 expression to an extent similar to HIF-1α siRNA, while 100 nM echinomycin reduces expression of these genes to below basal levels. The structure of double-helical DNA is not greatly perturbed by minor groove binding hairpin polyamides (22) ; echinomycin binding to DNA causes local unwinding and lengthening of the DNA helix, which might account for its greater potency in these experiments (28, 29) . Polyamideintercalator conjugates have been shown to unwind DNA in a sequence specific fashion and to improve the ability of a polyamide to inhibit the binding of several DNA binding proteins in vitro (30, 31) . Attempts to use polyamide-intercalator conjugates to target the VEGF HRE, however, have not been successful due to poor nuclear uptake. 
Microarray analysis of gene expression
One potential limitation to the use of hairpin-polyamides for regulation of target genes is the binding site size and specificity for match versus mismatch sites, which may result in a prohibitively large number of affected genes. To examine this, the global effects of polyamide treatment on hypoxia-induced gene expression were measured using Affymetrix Human Genome U133 Plus 2.0 Arrays which contain oligonucleotide sequences representing more than 50,000 transcripts. To establish a benchmark for comparison, the effects of siRNA against HIF-1α and echinomycin were also measured.
Experiments were conducted in triplicate, and gene expression levels were normalized to DFO-treated controls. Cells not treated with DFO were also normalized to DFO-treated controls. Microarray data was deposited in the NCBI Gene Expression Omnibus We find that DFO induced the expression of a set of 297 transcripts by at least 4-fold (p ≤ 0.01) (Figure 4 .4B) (Appendix A, Table A1 ). Of this set, 69 were inhibited by polyamide 1 by at least 2-fold (p ≤ 0.01) (Appendix A, Table A2 ). The HRE sequences for these genes, where known, are displayed in Table 4 .2.
Quantitative real-time RT-PCR was used to confirm the effects of polyamide and siRNA treatments on these genes. Chromatin immunoprecipitation was used to measure HIF-1 occupancy at the HREs of VEGF and carbonic anhydrase IX (CA9), which were both affected by polyamide 1, and those of BNIP3, and PGK1, which were unaffected ( Figure   4 .6). HIF-1α occupancy at the VEGF HRE was decreased by HIF-1α siRNA, echinomycin, and polyamide 1, but less so by treatment with 3. HIF-1 occupancy at the carbonic anhydrase IX locus was also decreased in the presence of 1, but not at that of BNIP3 or PGK1, consistent with the observed gene expression changes. It is interesting to note that all of the genes affected by polyamide 1 displayed in Table 2 
Discussion
In this experiment, polyamide 1 (1 μM) affected the expression of 2,284 transcripts by more than 2-fold (p ≤ 0.01), which represents less than 5% of the transcripts assayed. A search of the publicly available human genome for the sequence Interestingly, polyamide 1 (1 μM) affected the expression of fewer genes than siRNA targeted to HIF-1α under the conditions of the experiment. A direct comparison in genomic specificity between polyamide and siRNA, however, cannot be drawn from these limited data because a large proportion of the genes affected by the siRNA are likely a result of silencing the target gene, HIF-1α, and not due to off-target effects involving post-transcriptional silencing of mRNA using the RNA interference pathway (46) . If we eliminate from the total number of transcripts affected by the HIF-1α siRNA (48) (49) (50) . Echinomycin had been previously brought to the clinic as a cancer therapeutic in phase I and II trials (51) , based on observations that echinomycin exhibits potent anti-proliferative effects on several tumor derived cell lines (51, 52) . However, survival benefit was not established (51) . In light of the recent work by Melillo and colleagues, a re-examination of the clinical use of echinomycin in tumor types expected to be highly sensitive to HIF-1 activity may be justified (20) . The induction of pro-angiogenic, proliferative, metastatic, and glycolytic genes by HIF-1 are established as contributing to the cancer phenotype (10) . However, genes that promote cell death, such as BNIP3 and NIX (BNIP3L), are also induced by hypoxia through HIF-1 (53) . In this sense, HIF-1 plays dual roles in the survival and death pathways of tumor cells (11) . A functional separation of these targets of HIF-1 at the level of HIF-1 DNA binding might have clinical relevance (11) . Given sufficient knowledge of the particular regulatory sequences involved, one could, in principle, design a polyamide or cocktail of polyamides to affect a selected subset of target genes in the HIF-1 pathway, making use of the programmability of polyamide recognition for targeting particular HREs and flanking sequences. The utility of polyamides as regulators of hypoxia induced gene expression awaits continued study in small animal models of HIF-1 activity.
Methods
Synthesis of Polyamides. Polyamides were synthesized by solid-phase methods on
Kaiser oxime resin (Nova Biochem) (54) . Polyamides were cleaved from resin with 3,3'-diamino-N-methyl-dipropylamine and purified by reverse-phase HPLC. Isophthalic acid was activated with PyBOP (Nova Biochem) and conjugated to the polyamides as previously described (19) . Purities and identities of the polyamides were assessed by HPLC, UV-visible spectroscopy, and MALDI-ToF MS.
Determination of DNA-binding affinities and sequence specificities
Quantitative DNase I footprint titration experiments were used to measure the binding affinities of polyamides 1, 2, and echinomycin on 5' 32 P labeled fragments of pGL2-VEGF-Luc or pCSJFLT1 that contain the promoter sequences containing the HREs of the VEGF and FLT1 genes, respectively. Quantitative DNase I footprint titration experiments were conducted as reported previously (55) . according to manufacturer's protocols. Quantitative real-time RT-PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems) on an ABI 7300 instrument.
Measurement of hypoxia induced gene expression
Target gene mRNA was measured relative to ß-glucuronidase as an endogenous control.
Primer sequences are available upon request.
Chromatin Immunoprecipitation
U251 cells were plated in 15 cm diameter plates and left to attach overnight. Media, time course, DFO, polyamide, echinomycin, and siRNA treatments were the same as described above. After the 16 hour DFO treatment, cells were treated with 1%
formaldehyde for 10 minutes. Chromatin was isolated and sheared. HIF-1α antibodies (Novus Biologicals) were used to immunoprecipitate HIF-1 bound DNA fragments. After crosslink reversal, PCRs using primers targeted to the regions of interest were used to assess enrichment of bound fragments as compared to mock-precipitated (no antibody) controls. PCRs were monitored either using SYBR Green PCR Master Mix (Applied Biosystems) on an ABI 7300 instrument, or directly visualized using gel electrophoresis.
See Appendix C for a more detailed protocol.
Analysis of Gene Expression with Oligonucleotide Microarrays
U251 cells were plated in 12-well plates at a density of 40-60 x 10 3 cells per well.
Media, time course, DFO, polyamide, echinomycin, and siRNA treatments were the same as described above. RNA was isolated as previously described. From this point, sample preparation for the microarray experiments were carried out at the Millard and Muriel Jacobs Gene Expression Facility at Caltech. Labeled mRNA was hybridized to affymetrix Human 133 arrays according to established protocols. Gene expression was analyzed using Resolver (Rosetta Biosoftware, Seattle).
